Showing results (681-690 of 2,914) with videos related to

Sort By:
Pageof 292
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
Machine Learning to Predict Remission Between Six and 24 Months in Rheumatoid Arthritis: Insights from the JAK-pot CollaborationZubeyir Salis, Denis Mongin, Denis Choquette, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2026
Identifying systemic lupus erythematosus from serum proteomic profiles using machine learning and genetic risk stratificationMehmet Hocaoǧlu, Jishnu Das, Amr H Sawalha
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2026
Toll-like receptor 8 is a therapeutic target in rheumatoid arthritisYilan Guo, Tong Zhu, Xiaoqiao Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 28, 2026
Kidney Hematopoietic Stem and Progenitor Cells Contribute to Myeloid Development and Pathology in Lupus NephritisHansol Yi, Seyoung Jung, Jeong Ho Joo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2026
Functional Impact of Structural Damage in Psoriatic Arthritis: Insights from a Prospective Cohort StudyPankti Mehta, Shangyi Gao, Virginia Carrizo Abarza, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 23, 2026
Association of epigenetic trajectory with development of clinical rheumatoid arthritis in anti-citrullinated protein antibody positive individuals: Targeting Immune Responses for Prevention of Rheumatoid Arthritis (TIP-RA)E Barton Prideaux, David L Boyle, Eunice Choi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2026
Determinants of Difficult-to-Manage and Treatment-Refractory Axial Spondyloarthritis: A Cross-Sectional Analysis within a Longitudinal CohortPatricia Remalante-Rayco, Laura Passalent, Tina Chim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2026
Higher complement C4 gene copy number constitutes a shared genetic risk factor for giant cell arteritis and IgA vasculitisLaura Martínez-Gutiérrez, Gonzalo Borrego-Yaniz, José Hernández-Rodríguez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 13, 2022
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety FindingsJohn K Botson, Kenneth Saag, Jeff Peterson, et al.
Pageof 292